New insider activity at HCA Healthcare ( (HCA) ) has taken place on November 5, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Michael R McAlevey, the Executive Vice President and Chief Legal and Administrative Officer at HCA Healthcare, recently sold 3,892 shares of the company’s stock. This transaction amounted to a total value of $1,843,990.
Spark’s Take on HCA Stock
According to Spark, TipRanks’ AI Analyst, HCA is a Outperform.
HCA Healthcare’s overall stock score is driven by strong technical analysis and positive earnings call results, reflecting robust financial performance and upward guidance revision. However, financial risks due to high leverage and negative equity slightly temper the score. The valuation is fair, supporting the company’s growth potential.
To see Spark’s full report on HCA stock, click here.
More about HCA Healthcare
YTD Price Performance: 58.09%
Average Trading Volume: 1,279,219
Technical Sentiment Signal: Buy
Current Market Cap: $107.6B